PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
New data on East Asian populations will guide researchers and clinicians to develop novel therapeutic strategies tailored to individual lung cancer patients. - May 21, 2020 - Genome Institute of Singapore
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Florida Department of Agriculture and Consumer Services Approves Kaycha Labs for their USDA Approved Hemp Program - May 20, 2020 - Kaycha Labs
Design leader brings global experience to help build upon brand’s long-term growth opportunities. - May 19, 2020 - Domestic Medical Supply Coalition
DMS 100% domestic production of all PPE is spearheading and galvanizing the American worker and putting thousands back to work. Also in production at DMS are Washable and Reusable Surgical Caps and Slip Resistant Booties as well as a full array of fashionable Medical scrubs. - May 18, 2020 - Domestic Medical Supply Coalition
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
As more and more local and state agencies mandate their citizens wear face masks in public, the immediate need for all consumers is evident.
The latest report from the CDC states, “We now know from recent studies that a significant portion of individuals with coronavirus lack symptoms (“asymptomatic”)... - May 08, 2020 - Domestic Medical Supply Coalition
Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection. - May 04, 2020 - Orphan Reach
Gamers can join the livestream video game event on Tiltify, May 3-9, to raise funds for cutting-edge ALS research at the ALS Therapy Development Institute. - May 03, 2020 - ALS Therapy Development Institute
Relaxed Regulations Amid COVID-19 Make Extended Reach Possible - May 02, 2020 - Neurology Associates
Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing - April 30, 2020 - Life Science Strategy Group, LLC
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020 - ALS Therapy Development Institute
In the wake of the COVID-19 epidemic, UK company, Vestigo has launched a new website to promote its efforts to develop a digital tracing app called Dot2Dot and test the prototype within the next few weeks.
Dot2Dot will digitise the manual contact tracing procedures utilised by health professionals,... - April 17, 2020 - Vestigo
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
HealthWare Systems has earned its Better Business Bureau Accreditation. The revenue cycle management company is now a BBB Accredited Business. - March 20, 2020 - HealthWare Systems
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching treatments... - March 12, 2020 - Cayman Chemical Company
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group
The Cardiac & Vascular Institute (TCAVI) announced it is the first in Florida to perform a successful procedure in the PROMISE II pivotal study of the LimFlow Percutaneous Deep Vein Arterialization System for the treatment of “no option” Chronic Limb-Threatening Ischemia, a severe form... - February 20, 2020 - The Cardiac & Vascular Institute
The evaluation of new markets in which to expand and the retention of existing ones are the mainstay of the year which has just closed for the company, which has recorded a considerable growth in the Far East, Europe, Central and South America. The "Customer Satisfaction 2019" results are certainly noteworthy. Training remains the cornerstone of the activity, with more than 200 training sessions for Human and Vet distributors from over 90 countries and 1400 hours for company staff. - February 06, 2020 - ASA srl
The Pediatric Cancer Research Foundation (PCRF) is proud to award 6 new grants with a total of 18 grants in 2020. These new grants are comprised of three Basic Science, one Translational and three Emerging Research grants totaling $675,000. With these new additions, PCRF will fund over $2.2 million in... - January 25, 2020 - Pediatric Cancer Research Foundation
“It’s really incredible. For 15 years, Augie’s Quest has been dedicated to raising the critical funds and broad awareness needed to help fast-track ALS TDI’s cutting-edge ALS research – specifically providing ALS TDI with more than $150 million to advance its efforts to end ALS,” commented Steven Perrin Ph.D., CEO of ALS TDI. - January 24, 2020 - ALS Therapy Development Institute
North County Health Services (NCHS) will host its 3rd annual gala on April 4, 2020. The Passion for Healing “Roaring into the 20s” Gala will take place at the beautiful Westin Carlsbad Resort & Spa.
The event will feature a Roaring Twenties theme. Guests will be transported to another... - January 13, 2020 - NCHS
NF-kB is a protein complex that controls the transcription of DNA. It is a heterodimer sequestered in the cytoplasm. In response to activation NF-kB translocates to the nucleus to 'turn on' the expression of specific genes that keeps a cell proliferating and protects it from apoptosis. AbboMax has developed a panel of NF-kB related antibodies. - December 22, 2019 - AbboMax, Inc.
Three distinguished members of the American Association for Anatomy (AAA) have been elected by their American Association for the Advancement of Science (AAAS) peers to the 2019 Class of AAAS Fellows in three different sections. They are Drs. Rick Sumner (Medical Sciences), Lynne Opperman (Dentistry and Oral Health Sciences), and David Ornitz (Biological Sciences). - December 20, 2019 - American Association for Anatomy
The ALS Therapy Development Institute (ALS TDI), the world’s foremost drug discovery lab focused solely on finding treatments and cures for ALS, today proudly announced that it is featured in episode two of “The Age of A.I.,” a new YouTube Originals documentary series that takes an... - December 18, 2019 - ALS Therapy Development Institute
HealthWare Systems Launches Updated Website: Announcing updates to the revenue cycle management technology website, www.healthwaresystems.com. - December 13, 2019 - HealthWare Systems
On Monday it was announced that Pete Frates passed away due to complications from ALS. Pete was a leader in the ALS community and the inspiration for the Ice Bucket Challenge, which helped raise millions of dollars for ALS research and awareness. Though it has been five years since the Challenge, Pete’s... - December 11, 2019 - ALS Therapy Development Institute
The Space-X 19 was launched at 12:29 EST on December 5 last; on-board it carries some scientific experiments that will be undertaken on the International Space Station during the Beyond Mission, led by the Italian astronaut Luca Parmitano from the European Space Agency. - December 08, 2019 - ASA srl
Neurology Associates Neuroscience Center is hiring more board-certified neurologists to accommodate its increasing patient load.
To date, Neurology Associates employs six neurologists, several of whom specialize in areas including movement disorders, multiple sclerosis, epilepsy, and other neurological... - December 08, 2019 - Neurology Associates
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton.
Dr. Cherian... - November 28, 2019 - New York Imaging Specialists
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776.
New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes Computed... - November 28, 2019 - New York Imaging Specialists
On November 25, 2019, the FDA posted on their site 15 companies that received warning letters for illegally selling products containing cannabidiol (CBD), Red Pill Medical, Inc. was one of them.
“I know it may sound crazy, but I was pleased with the FDA warning letter,” said Gregory A. Smith,... - November 28, 2019 - Red Pill Medical, Inc.
The company from Veneto receives an award at the Creative Communication Award programme in Los Angeles for its campaigns dedicated to the HIRO TT and MiS devices. The award conferred for “Brand identity” is the result of the collaboration with Studio D’Orsi. - November 27, 2019 - ASA srl
TGF-β regulates multiple biological processes, including embryonic development, adult stem cell differentiation, proliferation, homeostasis, immune regulation, wound healing, and inflammation. Multiple cells synthesize TGF-β and many cells have specific receptors for this peptide. AbboMax created a panel of TGF-β and TGF-β receptors antibodies. AbboMax, Inc. has been developing & manufacturing antibodies, FFPE cell pellets slides, for many years in California. - November 23, 2019 - AbboMax, Inc.
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. Anelixis... - November 20, 2019 - ALS Therapy Development Institute
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
Nationwide Testing Association, Inc. recently launched a new resource center online. The resource center is aimed at keeping clients up-to-date on all things compliance. In Nationwide Testing Association, Inc.'s resource center, you will find training videos, and news releases on current industry topics. - November 05, 2019 - Nationwide Testing Association Inc.
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
The NIH’s National Institute of Arthritis and Musculoskeletal & Skin Diseases (NIAMS) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop its patented small molecule bone repair agent KMN-159. - September 25, 2019 - Cayman Chemical Company
Scintica Instrumentation Inc. is excited to announce its exclusive distribution agreement with Aspect Imaging for the M-Series(TM) MRI systems for scientific research. With more than 100 MRI installations worldwide, Aspect’s compact MRI systems are self-shielding, cryogen free and do not need any... - September 18, 2019 - Scintica Instrumentation
All Processes, Data Stay the Same for Patients, Providers - September 14, 2019 - Neurology Associates
On October 24, 2019 join the ALS Therapy Development Institute in Cambridge for an outdoor celebration of autumn with hard cider, apple cider donuts, seasonal snacks, music, and fun – all in support of a great cause. - September 10, 2019 - ALS Therapy Development Institute
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of expression... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Novel genomics and computational methods reveal how gene “switches” impact survival rates of cancer patients, paving the way to targeted cancer treatments. - September 08, 2019 - Genome Institute of Singapore
Biosynthetic Technologies (BT) today announced it has signed on with Cayman Chemical for the production and distribution of novel Estolide compounds for pharmaceutical testing applications. BT is excited to partner with Cayman Chemical to provide discovery and pre-clinical development services to the... - September 05, 2019 - Cayman Chemical Company
